<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
GANX
Gain Therapeutics
$
()


  • Gain Therapeutics announces preclinical data on class of allosteric regulators

    12/1/2023 - 08:08am
  • Gain Therapeutics prices 2.2M shares at $2.005 in public offering

    11/21/2023 - 08:58am
  • Fly Intel: After-Hours Movers

    11/20/2023 - 20:28pm
  • Gain Therapeutics files to sell common stock, no amount given

    11/20/2023 - 16:04pm
  • Gain Therapeutics reports Q3 EPS (37c), consensus (45c)

    11/14/2023 - 07:14am
  • Gain announces dosing of first two subjects in Phase 1 trial of GT-02287

    10/4/2023 - 07:01am
  • Gain Therapeutics initiated with a Buy at Maxim

    9/12/2023 - 07:34am
  • Gain Therapeutics announces preclinical data from drug candidate GT-02287

    8/28/2023 - 07:02am
  • Gain Therapeutics expects cash to fund operations into Q3 of 2024

    8/10/2023 - 07:14am
  • Gain Therapeutics announces upcoming milestones

    8/10/2023 - 07:14am
  • Gain Therapeutics reports Q2 EPS (62c), consensus (31c)

    8/10/2023 - 07:13am
  • Gain announces acceptance of late breaking abstract to present on GT-02287

    8/7/2023 - 07:08am
  • Gain Therapeutics price target raised to $6 from $5.75 at Chardan

    5/14/2023 - 20:43pm
  • Gain Therapeutics expects cash to fund operations into 3Q24

    5/12/2023 - 08:08am
  • Gain Therapeutics reports Q1 EPS (43c), consensus (39c)

    5/12/2023 - 08:07am
dynamic_feed Breaking News